Skip to main content

Published locations for FDA approves ibrutinib plus obinutuzumab for CLL/SLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves ibrutinib plus obinutuzumab for CLL/SLL

User login

  • Reset your password
  • /content/fda-approves-ibrutinib-plus-obinutuzumab-cll/sll
  • /hematologynews/article/193367/cll/fda-approves-ibrutinib-plus-obinutuzumab-cll/sll
  • /oncologypractice/article/193367/cll/fda-approves-ibrutinib-plus-obinutuzumab-cll/sll
  • /hematology-oncology/article/193367/cll/fda-approves-ibrutinib-plus-obinutuzumab-cll/sll
  • /hematologytimes/article/193367/cll/fda-approves-ibrutinib-plus-obinutuzumab-cll/sll
  • /b-cell-lymphoma-icymi/article/193367/cll/fda-approves-ibrutinib-plus-obinutuzumab-cll/sll